Original release date: October 7, 2024
USCAP Bone and Soft Tissue Pathology: Keep Calm and Navigate the Updates and Pitfalls 2024 The diagnosis of soft tissue tumors is challenging, even for experienced surgical pathologists. This inherent difficulty is compounded by the rapidly evolving classification of soft tissue tumors, as new entities and genetic alterations are being described at an unprecedented rate.medical-amboss.com Given the rarity of such tumors, the broad histologic spectrum of mesenchymal neoplasms, and resemblance to other mesenchymal and non-mesenchymal tumors, pathologists need an in-depth look at updates and potential pitfalls. This course, led by experts, will help alleviate these challenges through interactive discussions and illustrative cases.
Learning Objectives
Upon completion of this educational activity, learners will be able to:
- Recognize a wide spectrum of soft tissue tumors, including recently described entities.
- Develop diagnostic skills to avoid common pitfalls in the diagnosis of soft tissue tumors.
- Understand the role and limitations of immunohistochemical and molecular studies in the diagnosis of soft tissue tumors.
+ Topics:
Adipocytic and Myxoid Tumors – Ivy John, MD Section: 2 Presentations 1 Document
Vascular and Rhabdomyoblastic Tumors – Michael R. Clay, MD Section: 2 Presentations 2 Documents
Fibroblastic, Myofibroblastic, and So-Called Fibrohistiocytic Tumors – Karen J. Fritchie, MD Section: 2 Presentations 1 Document
Small Round Blue Cell and Epithelioid Tumors – Narasimhan Agaram, MBBS Section: 2 Presentations 2 Documents